OptiMedica's Catalys Precision Laser System, technology for performing cataract surgery, has earned a patent from the U.S. Patent & Trademark Office, according to a Fort Mills Times report.
The 3D image-based femtosecond laser system, co-invented by Dr. Daniel Palanker of Stanford University, will be issued the patent on March 12, 2013.
OptiMedica, based in Sunnyvale, Calif., is an ophthalmological device company.
More Articles on Ophthalmology:
EyeCare 20/20 First in New Jersey to Offer Catalys Treatment
Ophthalmology Startup Raises $7.9M in Capital for Retinal Microneedle Project
New Macular Degeneration Test Could Avert Vision Loss
The 3D image-based femtosecond laser system, co-invented by Dr. Daniel Palanker of Stanford University, will be issued the patent on March 12, 2013.
OptiMedica, based in Sunnyvale, Calif., is an ophthalmological device company.
More Articles on Ophthalmology:
EyeCare 20/20 First in New Jersey to Offer Catalys Treatment
Ophthalmology Startup Raises $7.9M in Capital for Retinal Microneedle Project
New Macular Degeneration Test Could Avert Vision Loss